Patent ID: 8362013

Claim:
The compound N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R1-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino-3-((trifluoromethyl)sulfonyl)benzenesulfonamide bis-hydrochloride (ABT-263 bis-HCl) in crystalline polymorph Form I thereof, characterized at least by a powder X-ray diffraction peak at any one or more of the following positions: 6.8, 7.2, 8.5, 18.5 and 18.7° 2θ, ±0.2° 2θ.